Ryan G. Paul

Ryan G. Paul

Auto-generated profile, based on publicly available information

Ryan G. Paul

Medical Research Centre, University of Waikato, Hamilton, New Zealand

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2019 in Skeletal Muscle
Verified
Journal Article
Open access
PDF file
RPRyan G. Paul
Ryan G. Paul
AHAlex S. Hennebry
Alex S. Hennebry
MEMarianne S. Elston
Marianne S. Elston
JCJohn V. Conaglen
John V. Conaglen
CMChris D. McMahon
Chris D. McMahon
Sexually dimorphic growth has been attributed to the growth hormone (GH)/insulin-like growth factor 1 (IGF1) axis, particularly GH-induced activation of the intracellular signal transducer and activator of transcription 5B (STAT5B), because deletion of STAT5B reduces body mass and the mass of skeletal muscles in male mice to that in female mice. However, it remains unclear why these effects are sex- and species-specific, because the loss of STAT5B retards growth in girls, but not in male mice. Our objectives were to determine whether sexually dimorphic growth of skeletal muscle persisted in STAT5B−/− mice and investigate the mechanisms by which STAT5B regulates sexually dimorphic growth. Blood and skeletal muscle were harvested from male and female STAT5B−/− mice and their wild-type littermates from the onset of puberty to adulthood. Growth of the skeleton and skeletal muscles was retarded in both sexes of STAT5B−/− mice, but more so in males. Although reduced, sexually dimorphic growth of skeletal muscle persisted in STAT5B−/− mice with an oxidative shift in the composition of myofibres in both sexes. Concentrations of IGF1 in blood and skeletal muscle were reduced in male STAT5B−/− mice at all ages, but only in female STAT5B−/− mice at the onset of puberty. Expression of androgen receptor (AR) and oestrogen receptor alpha (ERα) mRNA and protein was reduced in skeletal muscles of male and female STAT5B−/− mice, respectively. Loss of STAT5B abolished the sexually dimorphic expression of myostatin protein and Igf1, Ar, Erα, suppressor of cytokine signalling 2 (Socs2), and cytokine-inducible SH2-containing protein (Cis) mRNA in skeletal muscle. STAT5B appears to mediate GH signalling in skeletal muscles of male mice at all ages, but only until puberty in female mice. STAT5B also appears to mediate the actions of androgens and oestrogens in both male and female mice, but sexually dimorphic growth persists in STAT5B−/− mice.

5 March 2024 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
OSOscar T. Sergel-Stringer
Oscar T. Sergel-Stringer
BWBenjamin Wheeler
Benjamin Wheeler
SSSara Styles
Sara Styles
ABAlisa Boucsein
Alisa Boucsein
CLClaire S. Lever
Claire S. Lever
MBMartin I. de Bock
Martin I. de Bock
Aims: To explore the lived experiences of initiating real-time continuous glucose monitoring (rt-CGM) use in individuals with type 2 diabetes using insulin. Methods: Twelve semi-structured interviews were conducted amongst individuals with type 2 diabetes taking insulin who were enrolled in the 2GO-CGM randomised controlled trial and had completed 3 months of rtCGM. Interviews were transcribed verbatim and analysed to identify common themes regarding their experiences. Results: The interviews revealed three key themes: i) rtCGM as a facilitator of improved health behaviours; ii) the acceptability of rtCGM systems compared to capillary blood glucose testing; and iii) barriers to the continual usage of rtCGM technology – including: connection difficulties, longevity of the sensors, and local cutaneous reactions to the sensor adhesive. Conclusion: Adults on insulin with type 2 diabetes find rtCGM systems widely acceptable, and easier to engage with than traditional self-monitoring of capillary blood glucose.

20 December 2011 in Australian and New Zealand Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
PDF file
RPRyan G. Paul
Ryan G. Paul
MEMarianne S. Elston
Marianne S. Elston
AGAnthony J. Gill
Anthony J. Gill
DMDeborah Marsh
Deborah Marsh
IBIan Beer
Ian Beer
GMGoswin Y. Meyer-Rochow
Goswin Y. Meyer-Rochow

16 March 2020 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
LCLynne M. Chepulis
Lynne M. Chepulis
JTJade A. U. Tamatea
Jade A. U. Tamatea
CWChris Wang
Chris Wang
JGJohn Goldsmith
John Goldsmith
CMChristopher T. H. Mayo
Christopher T. H. Mayo
RPRyan G. Paul
Ryan G. Paul

18 February 2019 in Australian and New Zealand Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
PDF file
RPRyan Paul
Ryan Paul
CMCarissa Murugesh
Carissa Murugesh
LCLynne Chepulis
Lynne Chepulis
JTJade Tamatea
Jade Tamatea
LWLouise Wolmarans
Louise Wolmarans

24 February 2022 in Molecular Metabolism
Verified
Journal Article
Open access
KLKate Lee
Kate Lee
SVSanaz Vakili
Sanaz Vakili
HBHannah J. Burden
Hannah J. Burden
SAShannon Adams
Shannon Adams
GSGreg C. Smith
Greg C. Smith
PSPeter R. Shepherd
Peter R. Shepherd
The minor allele (A) of the rs373863828 variant (p.Arg457Gln) in CREBRF is restricted to indigenous peoples of the Pacific islands (including New Zealand Māori and peoples of Polynesia), with a frequency of up to 25% in these populations. This allele associates with a large increase in body mass index (BMI) but with significantly lower risk of type-2 diabetes (T2D). It remains unclear whether the increased BMI is driven by increased adiposity or by increased lean mass. We undertook body composition analysis using DXA in 189 young men of Māori and Pacific descent living in Aotearoa New Zealand. Further investigation was carried out in two orthologous Arg458Gln knockin mouse models on FVB/NJ and C57BL/6j backgrounds. The rs373863828 A allele was associated with lower fat mass when adjusted for BMI (p < 0.05) and was associated with significantly lower circulating levels of the muscle inhibitory hormone myostatin (p < 0.05). Supporting the human data, significant reductions in adipose tissue mass were observed in the knockin mice. This was more significant in older mice in both backgrounds and appeared to be the result of reduced age-associated increases in fat mass. The older male knockin mice on C57BL/6j background also had increased grip strength (p < 0.01) and lower levels of myostatin (p < 0.05). Overall, these results prove that the rs373863828 A-allele is associated with a reduction of myostatin levels which likely contribute to an age-dependent lowering of fat mass, at least in males.